![\"\"](\"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/03\/gene-dosing-1024x572.jpg\")
<\/h3>\n<\/h3>\nThere are hundreds of heart health apps on the market today. Most of them do the same thing: they monitor your heart rate, track your steps, measure your sleep, and tell you to eat more vegetables. Some of the more sophisticated ones connect to wearables and give you a real-time readout of your pulse. A few will even flag an irregular heartbeat.<\/p>\n
These are useful tools. But they are all answering a different question.<\/p>\n
Heart rate monitors tell you what your heart is doing right now. What they cannot tell you \u2014 what no wearable on your wrist can tell you \u2014 is what your heart is likely to do in ten, twenty, or thirty years based on the genetic blueprint you inherited from your family. That question requires a completely different kind of tool. And until now, no app has been built to answer it properly.<\/p>\n
That changes today.<\/p>\n
The Heart Risk Calculator is now available on Google Play, and it represents something genuinely new in the heart health app space. It is not a heart rate monitor. It is not a step counter. It is not a meditation timer or a blood pressure log. To our knowledge, it is among the first consumer apps designed specifically to quantify inherited cardiovascular risk using a weighted family-history framework \u2014 the Inherited Hazard Coefficient (IHC) \u2014 derived from principles established in peer-reviewed literature published in Circulation<\/em>, JAMA<\/em>, the European Heart Journal<\/em>, and the Lancet<\/em>. [1],[2],[3],[4]<\/sup><\/p>\n The core insight behind this app is simple but profound: your family history is not a yes or no question.<\/strong><\/p>\n Standard heart risk calculators \u2014 including the widely used Framingham Risk Score \u2014 ask whether you have a family history of heart disease. [1]<\/sup> Yes or no. That\u2019s it. A grandparent dying of a heart attack at 82 and a sibling collapsing from sudden cardiac death at 39 both get the same checkbox. They are not the same thing. Not even close. And the research is unambiguous about this. [3],[5]<\/sup><\/p>\n It Asks Who, Not Just Whether<\/strong><\/p>\n The Heart Risk Calculator organizes your family\u2019s cardiac history by relationship, age at event, and severity of outcome. A fatal event in a first-degree relative at age 40 carries a fundamentally different inherited signal than a non-fatal event in a grandparent at age 75. The app captures that difference mathematically, using an evidence-informed weighting framework developed from published epidemiologic observations by Peter Megdal, PhD:<\/p>\n H = \u03a3 (R \u00d7 W) \/ A<\/strong><\/p>\n Where R is the relation coefficient (0.5 for parents and siblings, 0.25 for grandparents and aunts and uncles), W is the severity weight of the cardiac event, and A is the age at which the event occurred. The equation is an evidence-informed educational framework that combines established epidemiologic risk principles into a structured score \u2014 providing a structured estimate of inherited familial cardiac risk that no standard checkbox can capture.<\/p>\n It Reveals the Imaging Trap<\/strong><\/p>\n One of the most important \u2014 and most alarming \u2014 findings in recent cardiovascular research is what clinicians call the Imaging Trap. A standard Coronary Artery Calcium scan, one of the most commonly used screening tools in cardiology, can return a score of zero even while dangerous soft, non-calcified plaque is actively building in your arteries. [6]<\/sup> For people with a significant inherited cardiac risk, a zero calcium score may provide false reassurance in selected patients.<\/p>\n The 2025 CAUGHT-CAD randomized trial confirmed that in patients with a family history of premature coronary artery disease, Coronary CT Angiography may identify non-calcified plaque not detected by calcium scoring and may influence management in selected patients. [7]<\/sup> The Heart Risk Calculator is built around this research. It helps you understand whether your family history pattern may place you among people for whom additional discussion with a physician about imaging options could be appropriate.<\/p>\n It Captures What Wearables Completely Miss<\/strong><\/p>\n Your Apple Watch knows your resting heart rate. It does not know that your brother had a fatal heart attack at 42. Your Fitbit tracks your sleep quality. It cannot tell you that a sibling with premature heart disease confers an odds ratio of 2.46 for your own cardiac risk \u2014 a figure documented in peer-reviewed research published in JAMA<\/em>. [5]<\/sup> Your Garmin measures your VO2 max. It has no way of accounting for the additive inherited burden \u2014 what researchers call gene dosing \u2014 that occurs when multiple close relatives develop premature cardiovascular disease, substantially increasing the probability of inherited genetic susceptibility. [3],[8]<\/sup><\/p>\n Wearables measure what is happening in your body right now. The Heart Risk Calculator models the inherited familial signal reflected in your family history and what it suggests about your lifetime cardiac trajectory. Wearables and family-history tools provide complementary but different information \u2014 but only one of them helps identify people who may benefit from more intensive evaluation than standard screening provides.<\/p>\n It Gives You Something to Bring to Your Doctor<\/strong><\/p>\n Every output from the Heart Risk Calculator is framed as a conversation starter, not a conclusion. The app generates a discussion-ready family history summary and a set of specific, clinically grounded questions you can bring to your next appointment. Questions like: given my family pattern, could I have soft plaque that a standard calcium scan would miss? Should I be referred to a preventive cardiologist rather than managed in primary care? Does my family history change how standard risk tools should be interpreted in my case? [9]<\/sup><\/p>\n These are the questions that can genuinely change the course of a clinical encounter. They are the questions that turn a routine annual physical into a meaningful cardiovascular conversation. And they are the questions that most people never know to ask \u2014 because no one has ever organized their family history in a way that makes those questions visible.<\/p>\n It Is Built on Real Science<\/strong><\/p>\n The Heart Risk Calculator is not a wellness app built on general advice. The concepts incorporated into its framework are informed by more than 40 peer-reviewed publications spanning inherited cardiac risk, premature coronary artery disease, family history epidemiology, and the genetics of cardiovascular susceptibility. The gene dosing model underlying the Inherited Hazard Coefficient draws on foundational research in inherited cardiovascular disease published in Nature Reviews Cardiology<\/em>, the Lancet<\/em>, and the European Heart Journal<\/em>. [4],[8]<\/sup> The parental and sibling risk data come from landmark studies in JAMA<\/em> and Circulation<\/em>. [3],[5]<\/sup> The clinical significance of early cardiac events in close relatives \u2014 and the inadequacy of standard tools in capturing that significance \u2014 is documented across decades of cardiovascular epidemiology. [9]<\/sup><\/p>\n This is not an algorithm someone built in a weekend. It is an evidence-informed educational framework, developed as an educational tool by Peter Megdal, PhD, that applies established epidemiologic principles to a problem that standard tools have never been designed to solve.<\/p>\n Why This Matters Right Now<\/strong><\/p>\n Heart disease remains the number one cause of death in the United States. [10]<\/sup> Roughly half of all Americans have a family history of cardiac events. [11]<\/sup> And yet the tools available to most people for understanding their inherited risk remain remarkably primitive \u2014 a checkbox on an intake form, a Framingham score that was never designed to capture genetic loading, [1]<\/sup> and a calcium scan that may miss the most dangerous plaque entirely in younger, gene-dosed individuals. [6],[9]<\/sup><\/p>\n For a 20-year-old whose sibling died of sudden cardiac death at 38, the Framingham Risk Score will often return a ten-year risk of under one percent \u2014 because the formula is driven by chronological age, not inherited biology. [1]<\/sup> That person\u2019s inherited risk profile may warrant substantially more evaluation than suggested by conventional calculators. And without a tool that models the inherited familial signal in their family history, they will never know to ask the right questions until it is too late.<\/p>\n The Heart Risk app exists for that person. It exists for everyone who has sat in a doctor\u2019s office and said \u201cyes, there\u2019s heart disease in my family\u201d and watched that information disappear into a checkbox that changes nothing about their care.<\/p>\n Download It Today<\/strong><\/p>\n The Heart Risk Calculator app is available now on Google Play for $4.99. It is an educational tool, not a medical device, and it does not replace clinical evaluation. But it may be the most important five dollars you spend on your heart health \u2014 not because it monitors your pulse, but because it finally asks the question that wearables and standard calculators have never been designed to answer.<\/p>\n Your family history is data. It\u2019s time to use it.<\/strong><\/p>\n This tool is for educational purposes only and does not constitute medical advice. The score has not been prospectively validated for predicting individual cardiovascular events and should not be used to diagnose disease. Always consult a qualified healthcare professional before making health decisions. Research by Peter Megdal, PhD \u2014 CuringHeartDisease.com<\/em><\/p>\n Companion document to: \u201cThe Heart Health App That Finally Asks the Right Question\u201d<\/em><\/p>\n The Inherited Hazard Coefficient (IHC) is computed using the formula:<\/p>\n H = \u03a3 (R \u00d7 W) \/ A<\/strong><\/p>\n Where R<\/strong> is the relation coefficient (0.5 for first-degree relatives: parents and siblings; 0.25 for second-degree relatives: grandparents, aunts, and uncles), W<\/strong> is the severity weight of the cardiac event, A<\/strong> is the age at which the event occurred, and \u03a3<\/strong> represents summation across all affected relatives in the family history.<\/p>\n Each structural element of this formula \u2014 the relation coefficient R, the severity weight W, the age denominator A, and the summation logic \u2014 is grounded in a specific body of peer-reviewed cardiovascular epidemiology. This addendum identifies the primary literature supporting each component and distinguishes that evidence from the design choices that represent the author\u2019s own evidence-informed synthesis.<\/p>\n The R term encodes the degree of biological relatedness between the patient and the affected family member. First-degree relatives (parents, siblings) receive a coefficient of 0.5, reflecting the 50% shared genome. Second-degree relatives (grandparents, aunts, uncles) receive 0.25, reflecting 25% shared genome. The differential weighting of first- versus second-degree relatives is supported by two landmark Framingham-based studies.<\/p>\n [1]<\/sup> This prospective Framingham offspring analysis was among the first to rigorously confirm parental cardiovascular disease as an independent predictor of offspring CVD after full adjustment for conventional risk factors. Critically, the study demonstrated that risk compounded when both<\/em> parents were affected \u2014 the conceptual foundation for the summation structure of the IHC. The paper directly supports the assignment of the 0.5 coefficient to parents and the differential weighting of first-degree versus second-degree relatives.<\/p>\n [2]<\/sup> This companion Framingham sibling analysis documented an unadjusted odds ratio of 2.46 for cardiovascular disease in individuals with an affected sibling \u2014 a magnitude comparable to or exceeding that of parental history in certain subgroups. This finding is the primary justification for assigning siblings the same R coefficient of 0.5 as parents, rather than a lower value. It also reinforced the core principle that first-degree relatives constitute a categorically different risk tier from second-degree relatives.<\/p>\n The A term places the age at which the family member experienced their cardiac event in the denominator of the formula, so that younger events produce a higher IHC contribution. This is the most clinically consequential structural feature of the algorithm and is supported by consistent findings across multiple data sources.<\/p>\n [1],[2]<\/sup> Both Framingham analyses stratified their findings by age at the family event and demonstrated substantially elevated risk when the cardiac event was premature \u2014 defined as occurring before age 55 in male relatives and before age 65 in female relatives. A family event at age 40 carries a fundamentally different inherited signal than the same event at age 78. The A term in the denominator is a direct mathematical encoding of this well-established epidemiologic principle.<\/p>\n [3]<\/sup> Cited in the main article as the primary example of a risk calculator that does not<\/em> account for age at the family event. The Framingham score uses the patient\u2019s own chronological age as its dominant driver of 10-year risk, but incorporates no variable for the age at which family members experienced cardiac events. The A denominator in the IHC formula is specifically designed to correct for this gap \u2014 capturing what the Framingham score systematically omits.<\/p>\n The W term assigns differential weights to cardiac events based on their severity \u2014 with fatal events, sudden cardiac death, and early revascularization receiving higher weights than medically managed non-fatal events. This reflects the well-documented relationship between event severity and underlying atherosclerotic burden.<\/p>\n [4]<\/sup> This large multicenter CCTA registry demonstrated that even among patients with a CAC score of zero \u2014 conventionally considered low risk \u2014 a meaningful proportion harbored non-calcified, potentially obstructive plaque. The study provided strong evidence that event severity and plaque characteristics are not uniform across patients with nominally similar risk profiles. Fatal events in first-degree relatives imply a higher inherited plaque burden and more aggressive disease trajectory than non-fatal, medically managed events \u2014 the epidemiologic rationale for the W severity weighting.<\/p>\n [5]<\/sup> This 2025 randomized trial in patients with a family history of premature CAD demonstrated that non-calcified plaque burden varied substantially even among individuals within the same broad family history category. The trial used CCTA to quantify plaque progression as its primary endpoint, confirming that severity differentiation within the inherited risk spectrum has measurable clinical significance \u2014 and is not captured by binary family history classification or calcium scoring alone.<\/p>\n The summation operator reflects the principle that inherited cardiac risk compounds with each additional affected relative. A patient with two affected first-degree relatives carries a meaningfully different inherited signal than a patient with one. The \u03a3 structure encodes this dose-response relationship mathematically.<\/p>\n [6]<\/sup> This large prospective study of men followed over decades demonstrated that family history of coronary heart disease death was associated with significantly elevated long-term cardiovascular mortality, and that the risk accumulated across the follow-up period in a manner consistent with an underlying dose-response relationship. The study supports the logic of summing contributions across affected relatives rather than treating family history as a single binary flag.<\/p>\n [7]<\/sup> This Mendelian randomization analysis demonstrated that the atherogenic effect of LDL cholesterol \u2014 the primary driver of inherited lipid-related cardiac risk \u2014 is cumulative and time-dependent. Lifetime exposure to elevated LDL produces atherosclerotic burden that is proportional to the integral of exposure over time, not simply to any single measurement. This biological framework supports the IHC summation structure: inherited cardiovascular risk is not a point estimate but a cumulative signal that should be aggregated across all affected relatives and weighted by the severity and timing of their events.<\/p>\n What is validated<\/strong><\/p>\n The peer-reviewed literature cited above establishes the following with high confidence:<\/p>\n What is not validated<\/strong><\/p>\n The existing literature does not<\/strong> validate:<\/p>\n The IHC formula is an evidence-informed educational framework<\/em> that translates established epidemiologic principles into a structured, quantitative estimate of inherited familial cardiac risk. The inputs are grounded in landmark peer-reviewed literature. The specific mathematical implementation \u2014 the coefficient values, the weighting scheme, and the formula structure \u2014 represents the author\u2019s synthesis of those principles and has not been independently validated. The ACC\/AHA Primary Prevention Guideline [8]<\/sup> explicitly recognizes family history as a risk-enhancing factor that should modify clinical decision-making, but stops short of providing a quantitative formula for doing so. The IHC is designed to fill precisely that gap.<\/p>\n Todos heredamos cosas de las personas que nos antecedieron. Puede que tengas los ojos azul brillante de tu abuela o la risa fuerte y contagiosa de tu padre. Estos rasgos son como reliquias familiares, transmitidos de generaci\u00f3n en generaci\u00f3n como un reloj preciado o una receta secreta. Pero en lo profundo de nuestras c\u00e9lulas, tambi\u00e9n heredamos \u201cmanuales de instrucciones\u201d llamados genes. La mayor\u00eda de las veces, estos manuales funcionan perfectamente para mantenernos sanos. Sin embargo, a veces contienen peque\u00f1os errores tipogr\u00e1ficos que pueden poner en peligro nuestros corazones.<\/p>","protected":false},"author":16,"featured_media":9812,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[257,219,220,225],"tags":[],"class_list":["post-9800","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genetics-and-family-risk","category-lipids-medications-and-testing","category-medications-and-treatments","category-risk-genetics-special-populations"],"acf":[],"yoast_head":"\nWhat Makes This App Different<\/h3>\n
References<\/h3>\n
\n
\nAddendum<\/h2>\n
Evidentiary Basis for the Inherited Hazard Coefficient Algorithm<\/h3>\n
Overview<\/h3>\n
The R Term: Relation Coefficient<\/h3>\n
Lloyd-Jones et al., JAMA 2004<\/h3>\n
Murabito et al., JAMA 2005<\/h3>\n
The A Term: Age at Event in the Denominator<\/h3>\n
Lloyd-Jones et al., JAMA 2004 and Murabito et al., JAMA 2005<\/h3>\n
D\u2019Agostino et al., Circulation 2008 \u2014 Framingham Risk Score<\/h3>\n
The W Term: Severity Weight<\/h3>\n
Villines et al., JACC 2011 \u2014 CONFIRM Registry<\/h3>\n
Nerlekar et al., JAMA 2025 \u2014 CAUGHT-CAD Trial<\/h3>\n
The \u03a3 Term: Summation Across Relatives<\/h3>\n
Bachmann et al., Circulation 2012 \u2014 Cooper Center Longitudinal Study<\/h3>\n
Ference et al., European Heart Journal 2017<\/h3>\n
What the Literature Validates \u2014 and What It Does Not<\/h3>\n
\n
\n
References<\/h3>\n
\n